← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2018Last known activity
Feb 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (8)
- NCT06803030Lead sponsorPhase 3Feb 1, 2025
- NCT06803030Sponsor investigatorPhase 3Feb 1, 2025
- NCT06620614OfficialPhase 1Oct 1, 2022
- NCT05995301Overall official - principal investigatorN/AMar 12, 2022
- NCT05995301Study chairN/AMar 12, 2022
- NCT05995301Study directorN/AMar 12, 2022
- NCT05997004Study chairN/AMay 1, 2018
- NCT05997004Overall official - principal investigatorN/AMay 1, 2018
Details
- Last known activity
- Feb 1, 2025